Codexis
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 174
- Market Cap
- $212.7M
- Website
- http://www.codexis.com
A Study of the Safety and Tolerability of CDX-6114 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CDX-6114Drug: Placebo
- First Posted Date
- 2019-01-09
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Codexis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03797664
- Locations
- 🇦🇺
Linear Clinical Services, Perth, Western Australia, Australia
Safety and Tolerability of CDX-6114 in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: CDX-6114Drug: Placebo
- First Posted Date
- 2018-07-05
- Last Posted Date
- 2018-09-20
- Lead Sponsor
- Codexis Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT03577886
- Locations
- 🇦🇺
Linear Clinical Services, Perth, Western Australia, Australia
© Copyright 2025. All Rights Reserved by MedPath